Podcast on Patients Rise presented by Charitable Pharmacies of America member, Dr. Hillary Blackburn, discussing impact of medication access on a community and health system, as well as patients.
Podcast on Patients Rise presented by Charitable Pharmacies of America member, Dr. Hillary Blackburn, discussing impact of medication access on a community and health system, as well as patients.
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
Uninsured adults and those in worse health continue to report higher rates of not getting care due to costs
A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.
We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…
‘Unbelievably good price’: KC-area pharmacy dispenses bargain medicine — and hope Go to article
How Many People Might Lose Medicaid When States Unwind Continuous Enrollment?
NOVA ScriptsCentral is excited to collaborate with the American Pharmacist Association to launch the “NOVA ScriptsCentral & American Pharmacist Association Safety-Net Health Equity Fellowship”.
Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected
Branson MO: My Neighbor’s Charitable Pharmacy (NCP) will open its doors at 1232 Branson Hills Parkway February of 2023
Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.
Charitable Pharmacies of America organization member receives Health Equity grant
Significant improvement in glycemic control among participants demonstrates the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D

